The event brought together 130 stakeholders from across South Australia’s cancer clinical trials sector, including trial coordinators, nurses, clinicians, researchers, governance and ethics staff, and partner organisations.
The event opened with Chief Cancer Officer Michael Osborn, followed by Prof Timothy Price who outlined the SACCaN Clinical Trials program, and then a series of quick-fire presentations from trial units across South Australia.
Pictured: Prof Timothy Price
The event provided attendees with the opportunity to connect in person, strengthen relationships and build a greater sense of community. It also created space to share insights, increase visibility of activity across the state, and support stronger collaboration between sites and organisations.
The SACCaN Clinical Trials Program aims to improve timely access to clinical trials across South Australia, by strengthening local research capacity and expanding opportunities for people to receive the latest treatments through statewide coordination.
The networking event supported this vision by facilitating collaboration and knowledge sharing. Of attendees surveyed post event, 95% met one to five new connections relevant to their work in clinical trials, and over 80% reported strengthening existing relationships.
Advancing quality in oesophago-gastric cancer care
The CEIH, in partnership with SACCaN, shared progress on the Optimal Care Pathways program at a recent Upper GI cancer research meeting in Adelaide, highlighting new work to measure and improve the quality of oesophago-gastric cancer care across SA.
A HOPEful approach to cancer navigation in South Australia
A new SACCaN sub-committee, HOPE, is focused on improving cancer navigation, survivorship and supportive care by strengthening collaboration and connections across the health system.
Optimal Care Pathways for fairer access to cancer care for all South Australians
The CEIH through the South Australian Comprehensive Cancer Network (SACCaN) is using Optimal Care Pathways (OCPs) to make access to high quality cancer care fairer for everyone, no matter where they live.